- Home
- PHAR vs NRDS Comparison
PHAR vs NRDS Comparison
Compare PHAR & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- NRDS
- Stock Information
- Founded
- PHAR 1988
- NRDS 2009
- Country
- PHAR Netherlands
- NRDS United States
- Employees
- PHAR N/A
- NRDS N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- NRDS EDP Services
- Sector
- PHAR Health Care
- NRDS Technology
- Exchange
- PHAR Nasdaq
- NRDS Nasdaq
- Market Cap
- PHAR 951.7M
- NRDS 785.4M
- IPO Year
- PHAR N/A
- NRDS 2021
- Fundamental
- Price
- PHAR $13.86
- NRDS $11.28
- Analyst Decision
- PHAR Strong Buy
- NRDS Buy
- Analyst Count
- PHAR 3
- NRDS 5
- Target Price
- PHAR $30.00
- NRDS $13.80
- AVG Volume (30 Days)
- PHAR 13.2K
- NRDS 485.7K
- Earning Date
- PHAR 10-23-2025
- NRDS 10-28-2025
- Dividend Yield
- PHAR N/A
- NRDS N/A
- EPS Growth
- PHAR N/A
- NRDS N/A
- EPS
- PHAR N/A
- NRDS 0.60
- Revenue
- PHAR $339,836,000.00
- NRDS $771,200,000.00
- Revenue This Year
- PHAR $16.63
- NRDS $16.45
- Revenue Next Year
- PHAR $6.77
- NRDS $7.85
- P/E Ratio
- PHAR N/A
- NRDS $18.53
- Revenue Growth
- PHAR 22.44
- NRDS 28.75
- 52 Week Low
- PHAR $7.31
- NRDS $7.55
- 52 Week High
- PHAR $17.08
- NRDS $16.45
- Technical
- Relative Strength Index (RSI)
- PHAR 51.52
- NRDS 60.38
- Support Level
- PHAR $13.63
- NRDS $10.77
- Resistance Level
- PHAR $15.27
- NRDS $11.39
- Average True Range (ATR)
- PHAR 0.98
- NRDS 0.36
- MACD
- PHAR -0.17
- NRDS 0.09
- Stochastic Oscillator
- PHAR 16.68
- NRDS 92.36
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.